The enrichment of immunologic gene sets, such as IL2-STAT5 signaling, IL6-JAK-STAT3 signaling, and inflammatory responses, varied across the cancer types, resulting in two tumor clusters (Fig. 6). This evidence concerns the gene IL6 and neoplasm.